Holen Sie sich die Stockscreener-App
1.16
7.20%
-0.09
Handel nachbörslich:
1.15
-0.01
-0.86%
Finanzdaten der Revelation Biosciences Inc-Aktie (REVB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
32.35%
2.5716
|
1.943 | 2.4612 | 2.095 | 1.7539 |
| Operating Income/Loss |
32.35%
-2.5716
|
-1.943 | -2.4612 | -2.095 | -1.7539 |
| Nonoperating Income/Loss |
69.06%
0.0606
|
0.0358 | 0.0168 | 0.0439 | 0.0282 |
| Income/Loss From Continuing Operations Before Tax |
31.66%
-2.511
|
-1.9072 | -2.4444 | -2.0511 | -1.7257 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
31.66%
-2.511
|
-1.9072 | -2.4444 | -2.0511 | -1.7257 |
|
Net Income/Loss
|
31.66%
-2.511
|
-1.9072 | -2.4444 | -2.0511 | -1.7257 |
| Preferred Stock Dividends And Other Adjustments |
100.00%
-
|
2.7697 | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
124.38%
-0.6448
|
2.6447 | 0.8027 | 0.9713 | -1.6334 |
| Diluted Average Shares |
124.38%
-0.6448
|
2.6447 | 0.8027 | 0.9713 | -1.6334 |
| Basic Earnings Per Share |
701.69%
-14.19
|
-1.77 | -7.01 | -2.11 | -80.30 |
| Diluted Earnings Per Share |
701.69%
-14.19
|
-1.77 | -7.01 | -2.11 | -80.30 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
100.00%
-
|
2.7697 | - | - | - |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):